The impact of Covid-19 for ongoing Clinical Trials could be significant and it is expected that the pandemic will interfere with the conduct of many of those Trials. The safety of study participants must be paramount, but there are also consequences for the methodological aspects of ongoing Clinical Trials and huge financial implications due to Covid-19.
This engaging and interactive module summarises the Regulatory Guidance issued to support the management of Clinical Trials during the Covid-19 pandemic and considers the practical implications of that guidance.
This module discusses Regulatory Guidance from:
All prices include VAT at 20%